These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting. Ahmed SS; Baba MZ; Wahedi U; Koppula J; Reddy MV; Selvaraj D; Venkatachalam S; Selvaraj J; Sankar V; Natarajan J Int J Biol Macromol; 2024 Nov; 279(Pt 1):135487. PubMed ID: 39349339 [TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan. Wu D; Zhu L; Li Y; Wang H; Xu S; Zhang X; Wu R; Yang G Int J Pharm; 2020 Jun; 584():119394. PubMed ID: 32407940 [TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926 [TBL] [Abstract][Full Text] [Related]
10. Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers. Liu Y; Zhang H; Cui H; Zhang F; Zhao L; Liu Y; Meng Q Drug Deliv; 2022 Dec; 29(1):342-350. PubMed ID: 35049388 [TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated alginate nanoparticles loaded hydrogel for the oral delivery of diferourylmethane in colorectal cancer. Abbasi M; Sohail M; Minhas MU; Mahmood A; Shah SA; Munir A; Kashif MU Int J Biol Macromol; 2023 Apr; 233():123585. PubMed ID: 36758757 [TBL] [Abstract][Full Text] [Related]
12. pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment. Nunes SS; Miranda SEM; de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; de Aguiar Ferreira C; Townsend DM; Cassali GD; Oliveira MC; Branco de Barros AL Biomed Pharmacother; 2021 Dec; 144():112317. PubMed ID: 34634556 [TBL] [Abstract][Full Text] [Related]
13. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
14. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management. Girotra P; Singh SK AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007 [TBL] [Abstract][Full Text] [Related]
15. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy. Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689 [TBL] [Abstract][Full Text] [Related]
16. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915 [TBL] [Abstract][Full Text] [Related]
17. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Pandey V; Gajbhiye KR; Soni V Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582 [TBL] [Abstract][Full Text] [Related]
18. Preparation and Optimization of Meropenem-Loaded Solid Lipid Nanoparticles: In Vitro Evaluation and Molecular Modeling. Mhango EKG; Kalhapure RS; Jadhav M; Sonawane SJ; Mocktar C; Vepuri S; Soliman M; Govender T AAPS PharmSciTech; 2017 Aug; 18(6):2011-2025. PubMed ID: 27933586 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology. Gidwani B; Vyas A Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752 [TBL] [Abstract][Full Text] [Related]
20. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]